847900-79-2 Usage
Chemical Family
2(1H)-Quinolinone, 7-bromo-4-phenylbelongs to the quinolinone family.
Structure
The compound has a bromine atom at the 7th position and a phenyl group at the 4th position.
Biological Activities
The compound exhibits a wide range of biological activities, including antibacterial, antitumor, anti-inflammatory, and analgesic properties.
Pharmaceutical Potential
The compound is a potential candidate for pharmaceutical development due to its diverse pharmacological activities.
Drug Development
2(1H)-Quinolinone, 7-bromo-4-phenylhas been the subject of research for its potential use in developing new drugs for the treatment of various diseases.
Unique Structure
The unique structure of the compound makes it an interesting target for further investigation in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 847900-79-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,7,9,0 and 0 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 847900-79:
(8*8)+(7*4)+(6*7)+(5*9)+(4*0)+(3*0)+(2*7)+(1*9)=202
202 % 10 = 2
So 847900-79-2 is a valid CAS Registry Number.
847900-79-2Relevant academic research and scientific papers
Part 3: Synthesis and biological evaluation of some analogs of the antitumor agents, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid, and 2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid
Hazeldine, Stuart T.,Polin, Lisa,Kushner, Juiwanna,White, Kathryn,Corbett, Thomas H.,Biehl, Jason,Horwitz, Jerome P.
, p. 1069 - 1081 (2007/10/03)
2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid (X469) and 2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic Acid (SH80) are among the most highly and broadly active antitumor agents to have been developed in our laboratories. However, the mecha
NOVEL FUSED TRIAZOLONES AND THE USES THEREOF
-
Page 118-119, (2010/02/08)
This invention relates to novel compounds having the structural diagram (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
